[LB-01] Late Breaking Symposium

[LB-01-02] Phase II Clinical Trial of Glycolipid OCH-NCNP1 for Patients with Relapsing Multiple Sclerosis

Tomoko Okamoto
Wakiro Sato
Youwei Lin
Yuko Shimizu
Yoichiro Nishida
Takanori Yokota
Takami Ishizuka
Harumasa Nakamura
Yuji Takahashi
Takashi Yamamura

(Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Japan)
(Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan)
(Department of Neurology, Tokyo Women's Medical University School of Medicine, Japan)
(Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan)
(Department of Clinical Research Support, Clinical Research & Education Promotion Division, National Center Hospital, National Center of Neurology and Psychiatry, Japan)